CA 19-9 and CA 125 Determination by Immunoluminometric Assay

Clinical Chemistry and Laboratory Medicine - Germany
doi 10.1515/cclm.1990.28.12.919
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Monitoring Ovarian Carcinoma With CA 125, CA 19–9, CA 15–3 and CEA in Serum, Ascites and Tumor Tissue

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Serum McA, CA 125 and CA 19.9 Determination in Primary Breast Cancer

Biochemical Society Transactions
Biochemistry
1996English

Tumor Markers CA 125 and CA 19–9 in Cord Blood and During Infancy: Developmental Changes and Use in Pediatric Germ Cell Tumors

Pediatric Research
Child HealthPediatricsPerinatology
1995English

Type 2 Dıabetes Mellıtus and CA 19-9 Levels

World Journal of Gastroenterology
MedicineGastroenterology
2007English

CA 19‐9‐producing Gastric Carcinoma: A Case Report

Advances in Digestive Medicine
2020English

Increased Serum CA 19-9 Antibodies in Sjogren's Syndrome.

Postgraduate Medical Journal
Medicine
1998English

CA 72-4 Compared With Cea and CA 19-9 as a Marker of Some Gastrointestinal Malignancies

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
1999English

Luminoimmunometric Assay of Tissue Polypeptide Antigen (Tpa) and Cancer Antigen 125 (Ca-125) in Breast Cancer Patients

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
1993English

Clinical Evaluation of Tumor Markers CA 19-9 and CA 125 in Diseases of the Digestive System: Diagnostic Usefulness Especially in Carcinoma of the Pancreas and Biliary Tract.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1985English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy